Updated Oct 6, 2025
Fred Siegel Of Beacon Capital Partners Secures $149.2M Loan From Morgan Stanley Bank In Boston
27 Drydock Avenue
$149,200,000
$521/SF
Building Size
286,000 SF
Asset Type
Life Sciences
Closing
Oct 2, 2025
About this deal
AI
The asset involved in the transaction is a life sciences-heavy office building located at 27 Drydock Avenue in Boston, MA, with a total square footage of 286,000. Beacon Capital Partners secured a loan amounting to $149,200,000 from Morgan Stanley Bank for refinancing purposes, replacing a previous $150,000,000 note from 2020.
Summary of transaction details:
- Property Type: Life Sciences
- Transaction Amount: $149,200,000
- Lender: Morgan Stanley Bank
- Landlord: Fred Siegel - Beacon Capital Partners
- Tenants: Includes Ginkgo Bioworks
This transaction signifies a shift in financing for Beacon Capital Partners under the representation of Fred Siegel, indicating the company's ongoing strategies amidst the current challenges faced in the life sciences market, particularly noted for tenant downsizing and space subleasing activities.
Players
Boston Life Sciences Market Snapshot
Boundary boundary · Life Sciences · Loan transactions
Loading comparables…
Deal FAQ
Browse Boston life sciences loans on Traded.
Purchase Price
Annual NOI
Loan Amount
Interest Rate (%)
Loan Term (yrs)
Down Payment (%)
Cap Rate
0.11%
Cash-on-Cash
-0.03%
Monthly Payment
$14,164
Annual Debt Svc
$169,964
Annual Cash Flow
$-11,334
DSCR
0.93